A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term ...
Researchers engineer monoclonal antibodies to selectively bind disease-associated proteins, enabling targeted prevention, detection, and treatment across multiple therapeutic areas. Unlike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results